Genetic Variation in SLC16A5 Confers Protection from Cisplatin-Induced Ototoxicity in Adult Testicular Cancer Patients

by Drogemoller, Britt, Monzon, Jose, Bhavsar, Amit, Borrie, Adrienne, Brooks, Beth, Wright, Galen, Liu, Geoffrey, Fadhel, Ehab, Renouf, Daniel, Kollmannsberger, Christian, Bedard, Philippe, Aminkeng, Folefac, Hildebrand, Claudette, Gunaretnam, Erandika, Critchley, Carol, Chen, Zhou, Brunham, Liam, Hayden, Michael, Ross, Colin, Gelmon, Karen, Carleton, Bruce
Published 2022

Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer

by Drogemoller, Britt I, Monzon, Jose G, Bhavsar, Amit P, Borrie, Adrienne E, Brooks, Beth, Wright, Galen EB, Liu, Geoffrey, Renouf, Daniel J, Kollmannsberger, Christian K, Bedard, Philippe L, Aminkeng, Folefac, Amstutz, Ursula, Hildebrand, Claudette A, Gunaretnam, Erandika P, Critchley, Carol, Chen, Zhuo, Brunham, Liam R, Hayden, Michael R, Ross, Colin JD, Gelmon, Karen A, Carleton, Bruce C
Published 2022

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

by Drogemoller, Britt I, Wright, Galen EB, Shih, Joanne, Monzon, Jose G, Gelmon, Karen A, Ross, Colin JD, Amstutz, Ursula, Carleton, Bruce C, Chang, Wan C, Connolly, Mary B, Dionne, Francois, Groeneweg, Gabriella, Loucks, Catrina M, MacLeod, Stuart M, Pritchard, Sheila, Rassekh, Shahrad R, Sanatani, Shubhayan, Bhavsar, Amit P, Rieder, Michael J, Shear, Neil H, Ito, Shinya, Liu, Geoffrey, Khayat, Philip, Bernstein, Daniel, Lesko, Lawrence J, Aminkeng, Folefac
Published 2022